Enfuvirtide

Enfuvirtide

CAT N°: 24097
Price:

From 48.00 40.80

Enfuvirtide is a biomimetic peptide inhibitor of HIV-1 fusion with CD4+ cells.{36579} It inhibits HIV-1 infectivity of HeLa cells stably expressing CD4 by the HXB2 strain (IC50 = 692 pM) and by clinical isolates (IC90s = 6.1-61 nM) in a single-cycle infectivity assay. It also inhibits genomic integration of HIV-1 into human intraepithelial vaginal cells and peripheral blood mononuclear cells (PBMCs; IC50s = 51.2 and 13.58 ?M, respectively).{36580} Enfuvirtide binds to a recombinant molecular mimic of HIV-1 glycoprotein gp41 that contains three N-terminal heptad and two C-terminal heptad repeat regions (Kd = 32 nM).{36581} It also binds to recombinant formyl peptide receptors (FPR) expressed in rat basophilic leukemia cells (IC50 = 5 nM) and attracts and activates human peripheral blood phagocytes, but not T lymphocytes, in vitro when used at a concentration of 100 nM.{36582} Formulations containing enfuvirtide have been used in combination therapy for the treatment of HIV-1/AIDS.

We also advise you